183 related articles for article (PubMed ID: 37665633)
1. PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia.
Carlock C; Bai Y; Paige-Hood A; Li Q; Nguele Meke F; Zhang ZY
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37665633
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of PRL2 phosphatase-mediated PTEN degradation and tumorigenesis.
Li Q; Bai Y; Lyle LT; Yu G; Amarasinghe O; Nguele Meke F; Carlock C; Zhang ZY
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20538-20548. PubMed ID: 32788364
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
[TBL] [Abstract][Full Text] [Related]
4. PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.
Chen H; Bai Y; Kobayashi M; Xiao S; Cai W; Barajas S; Chen S; Miao J; Meke FN; Vemula S; Ropa JP; Croop JM; Boswell HS; Wan J; Jia Y; Liu H; Li LS; Altman JK; Eklund EA; Ji P; Tong W; Band H; Huang DT; Platanias LC; Zhang ZY; Liu Y
Blood; 2023 Jan; 141(3):244-259. PubMed ID: 36206490
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.
Dong Y; Zhang L; Bai Y; Zhou HM; Campbell AM; Chen H; Yong W; Zhang W; Zeng Q; Shou W; Zhang ZY
J Biol Chem; 2014 Feb; 289(6):3799-810. PubMed ID: 24371141
[TBL] [Abstract][Full Text] [Related]
6. Phosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and activating Akt protein.
Dong Y; Zhang L; Zhang S; Bai Y; Chen H; Sun X; Yong W; Li W; Colvin SC; Rhodes SJ; Shou W; Zhang ZY
J Biol Chem; 2012 Sep; 287(38):32172-9. PubMed ID: 22791713
[TBL] [Abstract][Full Text] [Related]
7. PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Chen H; Bai Y; Kobayashi M; Xiao S; Barajas S; Cai W; Chen S; Miao J; Nguele Meke F; Yao C; Yang Y; Strube K; Satchivi O; Sun J; Rönnstrand L; Croop JM; Boswell HS; Jia Y; Liu H; Li LS; Altman JK; Eklund EA; Sukhanova M; Ji P; Tong W; Band H; Huang DT; Platanias LC; Zhang ZY; Liu Y
Mol Cancer Res; 2024 Jan; 22(1):94-103. PubMed ID: 37756563
[TBL] [Abstract][Full Text] [Related]
8. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
[TBL] [Abstract][Full Text] [Related]
10. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
11. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN.
Wang N; Yang B; Jin J; He Y; Wu X; Yang Y; Zhou W; He Z
J Gene Med; 2022 Mar; 24(3):e3404. PubMed ID: 34913223
[TBL] [Abstract][Full Text] [Related]
13. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.
Wey S; Luo B; Tseng CC; Ni M; Zhou H; Fu Y; Bhojwani D; Carroll WL; Lee AS
Blood; 2012 Jan; 119(3):817-25. PubMed ID: 21937694
[TBL] [Abstract][Full Text] [Related]
14. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia.
Zhiyong C; Wentong L; Xiaoyang Y; Ling P
Med Oncol; 2012 Jun; 29(2):1084-92. PubMed ID: 21360018
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells.
Yuan Z; Wang W
Hematology; 2020 Dec; 25(1):160-164. PubMed ID: 32319862
[No Abstract] [Full Text] [Related]
16. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway.
Li Y; Gao L; Luo X; Wang L; Gao X; Wang W; Sun J; Dou L; Li J; Xu C; Wang L; Zhou M; Jiang M; Zhou J; Caligiuri MA; Nervi C; Bloomfield CD; Marcucci G; Yu L
Blood; 2013 Jan; 121(3):499-509. PubMed ID: 23223432
[TBL] [Abstract][Full Text] [Related]
17. Pten, tumorigenesis, and stem cell self-renewal.
Rossi DJ; Weissman IL
Cell; 2006 Apr; 125(2):229-31. PubMed ID: 16630811
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis.
Bai Y; Zhou HM; Zhang L; Dong Y; Zeng Q; Shou W; Zhang ZY
Sci Rep; 2016 Sep; 6():34211. PubMed ID: 27666520
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Stem Cell Activity Is Regulated by Pten Phosphorylation Through a Niche-Dependent Mechanism.
Li J; Zhang J; Tang M; Xin J; Xu Y; Volk A; Hao C; Hu C; Sun J; Wei W; Cao Q; Breslin P; Zhang J
Stem Cells; 2016 Aug; 34(8):2130-44. PubMed ID: 27096933
[TBL] [Abstract][Full Text] [Related]
20. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
